Table of Content

Table of Contents
Table of Contents
1 Industry Overview
1.1 Primary Biliary Cirrhosis Drug Industry
Figure Primary Biliary Cirrhosis Drug Industry Chain Structure
1.1.1 Overview
1.1.2 Development of Primary Biliary Cirrhosis Drug
1.2 Market Segment
1.2.1 Upstream
Table Upstream Segment of Primary Biliary Cirrhosis Drug
1.2.2 Downstream
Table Application Segment of Primary Biliary Cirrhosis Drug
Table Global Primary Biliary Cirrhosis Drug Market 2016-2026, by Application, in USD Million
1.2.3 COVID-19 Impact
1.3 Cost Analysis
2 Industry Environment (PEST Analysis)
2.1 Policy
2.2 Economics
2.3 Sociology
2.4 Technology
3 Primary Biliary Cirrhosis Drug Market by Type
3.1 By Type
3.1.1 Budesonide
Table Major Company List of Budesonide
3.1.2 FFP-104
Table Major Company List of FFP-104
3.1.3 GSK-2330672
Table Major Company List of GSK-2330672
3.1.4 MBX-8025
Table Major Company List of MBX-8025
3.1.5 NGM-282
Table Major Company List of NGM-282
3.1.6 Others
Table Major Company List of Others
3.2 Market Size
Table Global Primary Biliary Cirrhosis Drug Market 2016-2020, by Type, in USD Million
Figure Global Primary Biliary Cirrhosis Drug Market Growth 2016-2020, by Type, in USD Million
Table Global Primary Biliary Cirrhosis Drug Market 2016-2020, by Type, in Volume
Figure Global Primary Biliary Cirrhosis Drug Market Growth 2016-2020, by Type, in Volume
3.3 Market Forecast
Table Global Primary Biliary Cirrhosis Drug Market Forecast 2021-2026, by Type, in USD Million
Table Global Primary Biliary Cirrhosis Drug Market Forecast 2021-2026, by Type, in Volume
4 Major Companies List
4.1 AlbireoPharma (Company Profile, Sales Data etc.)
4.1.1 AlbireoPharma Profile
Table AlbireoPharma Overview List
4.1.2 AlbireoPharma Products & Services
4.1.3 AlbireoPharma Business Operation Conditions
Table Business Operation of AlbireoPharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.2 CymaBay Therapeutics, Inc. (Company Profile, Sales Data etc.)
4.2.1 CymaBay Therapeutics, Inc. Profile
Table CymaBay Therapeutics, Inc. Overview List
4.2.2 CymaBay Therapeutics, Inc. Products & Services
4.2.3 CymaBay Therapeutics, Inc. Business Operation Conditions
Table Business Operation of CymaBay Therapeutics, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.3 Dr. Falk Pharma GmbH (Company Profile, Sales Data etc.)
4.3.1 Dr. Falk Pharma GmbH Profile
Table Dr. Falk Pharma GmbH Overview List
4.3.2 Dr. Falk Pharma GmbH Products & Services
4.3.3 Dr. Falk Pharma GmbH Business Operation Conditions
Table Business Operation of Dr. Falk Pharma GmbH (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.4 Enanta Pharmaceuticals, Inc. (Company Profile, Sales Data etc.)
4.4.1 Enanta Pharmaceuticals, Inc. Profile
Table Enanta Pharmaceuticals, Inc. Overview List
4.4.2 Enanta Pharmaceuticals, Inc. Products & Services
4.4.3 Enanta Pharmaceuticals, Inc. Business Operation Conditions
Table Business Operation of Enanta Pharmaceuticals, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.5 GlaxoSmithKline Plc (Company Profile, Sales Data etc.)
4.5.1 GlaxoSmithKline Plc Profile
Table GlaxoSmithKline Plc Overview List
4.5.2 GlaxoSmithKline Plc Products & Services
4.5.3 GlaxoSmithKline Plc Business Operation Conditions
Table Business Operation of GlaxoSmithKline Plc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.6 Intercept Pharmaceuticals, Inc. (Company Profile, Sales Data etc.)
4.6.1 Intercept Pharmaceuticals, Inc. Profile
Table Intercept Pharmaceuticals, Inc. Overview List
4.6.2 Intercept Pharmaceuticals, Inc. Products & Services
4.6.3 Intercept Pharmaceuticals, Inc. Business Operation Conditions
Table Business Operation of Intercept Pharmaceuticals, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.7 Johnson & Johnson (Company Profile, Sales Data etc.)
4.7.1 Johnson & Johnson Profile
Table Johnson & Johnson Overview List
4.7.2 Johnson & Johnson Products & Services
4.7.3 Johnson & Johnson Business Operation Conditions
Table Business Operation of Johnson & Johnson (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.8 MediGene AG (Company Profile, Sales Data etc.)
4.8.1 MediGene AG Profile
Table MediGene AG Overview List
4.8.2 MediGene AG Products & Services
4.8.3 MediGene AG Business Operation Conditions
Table Business Operation of MediGene AG (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.9 NGM Biopharmaceuticals, Inc. (Company Profile, Sales Data etc.)
4.9.1 NGM Biopharmaceuticals, Inc. Profile
Table NGM Biopharmaceuticals, Inc. Overview List
4.9.2 NGM Biopharmaceuticals, Inc. Products & Services
4.9.3 NGM Biopharmaceuticals, Inc. Business Operation Conditions
Table Business Operation of NGM Biopharmaceuticals, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.10 Virobay Inc. (Company Profile, Sales Data etc.)
4.10.1 Virobay Inc. Profile
Table Virobay Inc. Overview List
4.10.2 Virobay Inc. Products & Services
4.10.3 Virobay Inc. Business Operation Conditions
Table Business Operation of Virobay Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
5 Market Competition
5.1 Company Competition
Table Global Primary Biliary Cirrhosis Drug Sales Revenue 2016-2020, by Company, in USD Million
Table Global Primary Biliary Cirrhosis Drug Sales Revenue Share 2016-2020, by Company, in USD Million
Figure Global Primary Biliary Cirrhosis Drug Sales Revenue Share in 2020, by Company, in USD Million
Table Global Primary Biliary Cirrhosis Drug Sales Volume 2016-2020, by Company, in Volume
Table Global Primary Biliary Cirrhosis Drug Sales Volume Share 2016-2020, by Company, in Volume
Figure Global Primary Biliary Cirrhosis Drug Sales Volume Share in 2020, by Company, in Volume
5.2 Regional Market by Company
Figure North America Primary Biliary Cirrhosis Drug Market Concentration, in 2020
Figure Europe Primary Biliary Cirrhosis Drug Market Market Concentration, in 2020
Figure Asia-Pacific Primary Biliary Cirrhosis Drug MMarket Concentration, in 2020
Figure South America Primary Biliary Cirrhosis Drug Market Concentration, in 2020
Figure Middle East & Africa Primary Biliary Cirrhosis Drug Market Concentration, in 2020
6 Demand by End Market
6.1 Demand Situation
6.1.1 Demand in Clinic
Figure Primary Biliary Cirrhosis Drug Demand in Clinic, 2016-2020, in USD Million
Figure Primary Biliary Cirrhosis Drug Demand in Clinic, 2016-2020, in Volume
6.1.2 Demand in Hospital
Figure Primary Biliary Cirrhosis Drug Demand in Hospital, 2016-2020, in USD Million
Figure Primary Biliary Cirrhosis Drug Demand in Hospital, 2016-2020, in Volume
6.1.3 Demand in Others
Figure Primary Biliary Cirrhosis Drug Demand in Others, 2016-2020, in USD Million
Figure Primary Biliary Cirrhosis Drug Demand in Others, 2016-2020, in Volume
6.2 Regional Demand Comparison
Table Regional Demand Comparison List
Table Major Application in Different Regions
6.3 Demand Forecast
Table Primary Biliary Cirrhosis Drug Demand Forecast 2021-2026, by Application, in USD Million
Figure Primary Biliary Cirrhosis Drug Market Growth 2021-2026, by Application, in USD Million
Figure Primary Biliary Cirrhosis Drug Market Share in 2026, by Application, in USD Million
Table Primary Biliary Cirrhosis Drug Demand Forecast 2021-2026, by Application, in Volume
Table Primary Biliary Cirrhosis Drug Market Growth 2021-2026, by Application, in Volume
Table Primary Biliary Cirrhosis Drug Market Share in 2026, by Application, in Volume
6.4 Impact of the COVID-19 on the Demand
7 Region Operation
7.1 Regional Production
Table Primary Biliary Cirrhosis Drug Production 2016-2020, by Region, in USD Million
Table Primary Biliary Cirrhosis Drug Production 2016-2020, by Region, in Volume
7.2 Regional Market
Table Global Primary Biliary Cirrhosis Drug Market 2016-2020, by Region, in USD Million
Table Global Primary Biliary Cirrhosis Drug Market Share 2016-2020, by Region, in USD Million
Table Global Primary Biliary Cirrhosis Drug Market 2016-2020, by Region, in Volume
Table Global Primary Biliary Cirrhosis Drug Market Share 2016-2020, by Region, in Volume
7.3 by Region
7.3.1 North America
7.3.1.1 Overview
Figure North America Primary Biliary Cirrhosis Drug Market Size and Growth 2016-2020, in USD Million
Figure North America Primary Biliary Cirrhosis Drug Market Size and Growth 2016-2020, in Volume
7.3.1.2 by Country (U.S., Canada, Mexico)
Table North America Primary Biliary Cirrhosis Drug Market Size 2016-2020, by Country, in USD Million
Table North America Primary Biliary Cirrhosis Drug Market Size 2016-2020, by Country, in Volume
7.3.2 Europe
7.3.2.1 Overview
Figure Europe Primary Biliary Cirrhosis Drug Market Size and Growth 2016-2020, in USD Million
Figure Europe Primary Biliary Cirrhosis Drug Market Size and Growth 2016-2020, in Volume
7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)
Table Europe Primary Biliary Cirrhosis Drug Market Size 2016-2020, by Country, in USD Million
Table Europe Primary Biliary Cirrhosis Drug Market Size 2016-2020, by Country, in Volume
7.3.3 Asia-Pacific
7.3.3.1 Overview
Figure Asia-Pacific Primary Biliary Cirrhosis Drug Market Size and Growth 2016-2020, in USD Million
Figure Asia-Pacific Primary Biliary Cirrhosis Drug Market Size and Growth 2016-2020, in Volume
7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)
Table Asia-Pacific Primary Biliary Cirrhosis Drug Market Size 2016-2020, by Country, in USD Million
Table Asia-Pacific Primary Biliary Cirrhosis Drug Market Size 2016-2020, by Country, in Volume
7.3.4 South America
7.3.4.1 Overview
Figure South America Primary Biliary Cirrhosis Drug Market Size and Growth 2016-2020, in USD Million
Figure South America Primary Biliary Cirrhosis Drug Market Size and Growth 2016-2020, in Volume
7.3.4.2 by Country (Brazil, Argentina etc.)
Table South America Primary Biliary Cirrhosis Drug Market Size 2016-2020, by Country, in USD Million
Table South America Primary Biliary Cirrhosis Drug Market Size 2016-2020, by Country, in Volume
7.3.5 Middle East & Africa
7.3.5.1 Overview
Figure Middle East & Africa Primary Biliary Cirrhosis Drug Market Size and Growth 2016-2020, in USD Million
Figure Middle East & Africa Primary Biliary Cirrhosis Drug Market Size and Growth 2016-2020, in Volume
7.3.5.2 by Country (Saudi Arabia, South Africa etc.)
Table Middle East & Africa Primary Biliary Cirrhosis Drug Market Size 2016-2020, by Country, in USD Million
Table Middle East & Africa Primary Biliary Cirrhosis Drug Market Size 2016-2020, by Country, in Volume
7.4 Regional Import & Export
7.5 Regional Forecast
Table Primary Biliary Cirrhosis Drug Market Forecast 2021-2026, by Region, in USD Million
Table Primary Biliary Cirrhosis Drug Market Forecast 2021-2026, by Region, in Volume
8 Marketing & Price
8.1 Price and Margin
8.1.1 Price Trends
8.1.2 Factors of Price Change
Table Price Factors List
8.1.3 Manufacturers Gross Margin Analysis
8.2 Marketing Channel
Figure Marketing Channels Overview
9 Research Conclusion

List of Figure

List of Table
List of Table
1. Table Upstream Segment of Primary Biliary Cirrhosis Drug
2. Table Application Segment of Primary Biliary Cirrhosis Drug
3. Table Global Primary Biliary Cirrhosis Drug Market 2016-2026, by Application, in USD Million
4. Table Major Company List of FFP-104
5. Table Major Company List of GSK-2330672
6. Table Major Company List of MBX-8025
7. Table Major Company List of NGM-282
8. Table Major Company List of Others
9. Table Global Primary Biliary Cirrhosis Drug Market 2016-2020, by Type, in USD Million
10. Table Global Primary Biliary Cirrhosis Drug Market 2016-2020, by Type, in Volume
11. Table Global Primary Biliary Cirrhosis Drug Market Forecast 2021-2026, by Type, in USD Million
12. Table Global Primary Biliary Cirrhosis Drug Market Forecast 2021-2026, by Type, in Volume
13. Table AlbireoPharma Overview List
14. Table Business Operation of AlbireoPharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
15. Table CymaBay Therapeutics, Inc. Overview List
16. Table Business Operation of CymaBay Therapeutics, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
17. Table Dr. Falk Pharma GmbH Overview List
18. Table Business Operation of Dr. Falk Pharma GmbH (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
19. Table Enanta Pharmaceuticals, Inc. Overview List
20. Table Business Operation of Enanta Pharmaceuticals, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
21. Table GlaxoSmithKline Plc Overview List
22. Table Business Operation of GlaxoSmithKline Plc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
23. Table Intercept Pharmaceuticals, Inc. Overview List
24. Table Business Operation of Intercept Pharmaceuticals, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
25. Table Johnson & Johnson Overview List
26. Table Business Operation of Johnson & Johnson (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
27. Table MediGene AG Overview List
28. Table Business Operation of MediGene AG (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
29. Table NGM Biopharmaceuticals, Inc. Overview List
30. Table Business Operation of NGM Biopharmaceuticals, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
31. Table Virobay Inc. Overview List
32. Table Business Operation of Virobay Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
33. Table Global Primary Biliary Cirrhosis Drug Sales Revenue 2016-2020, by Company, in USD Million
34. Table Global Primary Biliary Cirrhosis Drug Sales Revenue Share 2016-2020, by Company, in USD Million
35. Table Global Primary Biliary Cirrhosis Drug Sales Volume 2016-2020, by Company, in Volume
36. Table Global Primary Biliary Cirrhosis Drug Sales Volume Share 2016-2020, by Company, in Volume
37. Table Regional Demand Comparison List
38. Table Major Application in Different Regions
39. Table Primary Biliary Cirrhosis Drug Demand Forecast 2021-2026, by Application, in USD Million
40. Table Primary Biliary Cirrhosis Drug Demand Forecast 2021-2026, by Application, in Volume
41. Table Primary Biliary Cirrhosis Drug Market Growth 2021-2026, by Application, in Volume
42. Table Primary Biliary Cirrhosis Drug Market Share in 2026, by Application, in Volume
43. Table Primary Biliary Cirrhosis Drug Production 2016-2020, by Region, in USD Million
44. Table Primary Biliary Cirrhosis Drug Production 2016-2020, by Region, in Volume
45. Table Global Primary Biliary Cirrhosis Drug Market 2016-2020, by Region, in USD Million
46. Table Global Primary Biliary Cirrhosis Drug Market Share 2016-2020, by Region, in USD Million
47. Table Global Primary Biliary Cirrhosis Drug Market 2016-2020, by Region, in Volume
48. Table Global Primary Biliary Cirrhosis Drug Market Share 2016-2020, by Region, in Volume
49. Table North America Primary Biliary Cirrhosis Drug Market Size 2016-2020, by Country, in USD Million
50. Table North America Primary Biliary Cirrhosis Drug Market Size 2016-2020, by Country, in Volume
51. Table Europe Primary Biliary Cirrhosis Drug Market Size 2016-2020, by Country, in USD Million
52. Table Europe Primary Biliary Cirrhosis Drug Market Size 2016-2020, by Country, in Volume
53. Table Asia-Pacific Primary Biliary Cirrhosis Drug Market Size 2016-2020, by Country, in USD Million
54. Table Asia-Pacific Primary Biliary Cirrhosis Drug Market Size 2016-2020, by Country, in Volume
55. Table South America Primary Biliary Cirrhosis Drug Market Size 2016-2020, by Country, in USD Million
56. Table South America Primary Biliary Cirrhosis Drug Market Size 2016-2020, by Country, in Volume
57. Table Middle East & Africa Primary Biliary Cirrhosis Drug Market Size 2016-2020, by Country, in USD Million
58. Table Middle East & Africa Primary Biliary Cirrhosis Drug Market Size 2016-2020, by Country, in Volume
59. Table Primary Biliary Cirrhosis Drug Market Forecast 2021-2026, by Region, in USD Million
60. Table Primary Biliary Cirrhosis Drug Market Forecast 2021-2026, by Region, in Volume
61. Table Price Factors List